Day: March 19, 2021

Suresnes, le 19 mars 2021, 8h45BelInformation financière annuelleRésultats 2020Bonne résilience dans un contexte de crise pandémiqueRenforcement des engagements RSEAccélération de la transformationLes montants sont exprimés en millions d’euros et arrondis au million le plus proche. Les ratios et écarts sont calculés à partir des montants sous-jacents et non à partir des montants arrondis.Au cours de sa séance du 18 mars 2021, le Conseil d’administration du groupe Bel, réuni sous la présidence de Monsieur Antoine Fievet, a arrêté les comptes consolidés de l’exercice clos le 31 décembre 2020. Lors de cette réunion, les Commissaires aux comptes ont indiqué que les procédures d’audit sur les comptes consolidés ont été effectuées et que le rapport de certification était en cours d’émission.Antoine Fievet, Président-Directeur Général du groupe...

Suresnes, 19 March 2021 – 8h45amBelAnnual financial information2020 ResultsCompany shows strong resilience in pandemic-related crisis environment and strengthens its CSR commitmentsTransformation continues apaceAmounts are expressed in millions of euros and rounded off to the nearest million. Ratios and variances are calculated based on underlying amounts, not rounded off amounts.Meeting March 18, 2021 under the chairmanship of Antoine Fievet, the Bel Group’s Board of Directors approved the consolidated financial statements for the year ended December 31, 2020. The Board was informed that the statutory auditors had completed their audit of the consolidated financial statements and that their report was forthcoming.Antoine Fievet, Chairman and Chief Executive Office of the Bel Group, commented: “The pandemic-related crisis we...

Kinnevik AB (publ) (“Kinnevik”) today announced that its Nomination Committee proposes the election of James Anderson as new Chairman of the Board and Harald Mix as new Director of the Board at the Annual General Meeting in April 2021. The Committee further proposes the re-election of Susanna Campbell, Brian McBride, Charlotte Strömberg and Cecilia Qvist as Directors of the Board. Dame Amelia Fawcett, Henrik Poulsen and Wilhelm Klingspor will not stand for re-election.Anders Oscarsson, Chairman of the Nomination Committee, said: ” Last year, my colleagues and I set out to reshape the Board of Kinnevik, primarily focusing on recruiting individuals who represent innovative and global investment excellence. The timing has been fortuitous for us as shareholders. This morning it was announced that James Anderson will be leaving Baillie...

Kinnevik AB (publ) (”Kinnevik”) meddelande idag att valberedningen föreslår val av  James Anderson till ny styrelseordförande och val av Harald Mix till ny styrelseledamot vid årsstämman i april 2021. Vidare förslår valbereningen återval av Susanna Campbell, Brian McBride, Charlotte Strömberg och Cecilia Qvist till styrelseledamöter. Dame Amelia Fawcett, Henrik Poulsen och Wilhelm Klingspor ställer inte upp till omval.Anders Oscarsson, ordförande för valberedningen sa:”Förra året började jag och mina kollegor arbetet med att omforma Kinneviks styrelse, främst med fokus på att rekrytera individer som representerar innovativ och global spetskompetens inom investeringar. Timingen har varit lyckosam för oss som aktieägare. Imorse meddelades att James Anderson kommer lämna Baillie Gifford i april 2022 efter vad som kommer att ha varit 39 utomordentligt...

Suresnes, le 19 mars 2021 – 8h45Bel annonce son intention de déposer un projet d’offre publique de rachat d’actions (« OPRA ») à un prix de 440 €1 faisant ressortir une prime de 28 %2Le Conseil d’administration de Bel a, dans sa séance du 18 mars 2021, approuvé l’entrée en négociation exclusive avec le Groupe Lactalis concernant la cession d’un périmètre comprenant Royal Bel Leerdammer NL, Bel Italia, Bel Deutschland, la marque Leerdammer® et tous ses droits attachés, ainsi que Bel Shostka Ukraine.Ce périmètre serait transféré à Lactalis par Sicopa, filiale détenue à 100% par Bel, en échange de 1.591.472 actions Bel (représentant 23,16% du capital) détenues par Lactalis. A l’issue de l’échange, Lactalis détiendrait 0,90% du capital de Bel. Au 31 décembre 2020, le chiffre d’affaires de la marque Leerdammer et de Bel Shostka Ukraine...

Suresnes, 19 March 2021 – 8:45amBel announces its intention to file a planned public share buyback tender offer (“OPRA”) at €440 per share1 including a 28% premium2The Bel Group board of directors at its 18 March 2021 meeting approved the start of exclusive negotiations with Lactalis Group involving the sale of a business including Royal Bel Leerdammer NL, Bel Italia, Bel Deutschland, the Leerdammer brand and all related rights, as well as Bel Shostka Ukraine.Sicopa, a wholly-owned Bel subsidiary, will sell said assets to Lactalis in return for 1,591,472 Bel shares (23.16% equity stake) held by Lactalis. Following the transaction, Lactalis will hold a 0.90% stake in Bel. 2020 Leerdammer and Bel Shostka Ukraine revenues were approximately €500 million, of which €350 million Leerdammer revenues, while operating earnings were approximately...

Today, 19 March 2021, the Board of Directors approved the Annual Report for 2020.Please find the Annual Report 2020 in Norwegian and English, including the ESG Report (Chapter 5) attached.For further information, please contact:Jon Olav Ødegård, CFO of Hofseth BioCare ASAPhone: +47 93632966E-mail: joo@hofsethbiocare.noAbout Hofseth BioCare ASA:HBC is a Norwegian biotech company developing high-value ingredients and finished products currently targeting the consumer health market. Research is ongoing to identify the individual elements within the products that modulate inflammation and the immune response with pre-clinical studies in multiple clinics and university research labs in several countries. Lead clinical and pre-clinical candidates are in development for the protection of the Gastro-Intestinal (GI) system against inflammation,...

19 March 2021Acron Group’s 2020 IFRS Revenue Up 4%Today Acron (Moscow Exchange and LSE: AKRN) released its audited consolidated IFRS financial statements for 2020.Key FinancialsRevenue was up 4% year-on-year to RUB 119,864 million (USD 1,661 million) from RUB 114,835 million (USD 1,774 million).EBITDA* was down 1% year-on-year to RUB 35,311 million (USD 489 million) from RUB 35,749 million (USD 552 million).EBITDA margin was 29%, against 31% a year before.Net profit was down to RUB 3,836 million (USD 53 million) from RUB 24,786 million (USD 383 million) a year before.Net debt in dollar terms was up 11% to USD 1,348 million from USD 1,215 million as of 2019 year-end.Net debt/EBITDA ratio in dollar terms increased to 2.8 from 2.2 as of 2019 year-end.Operating ResultsOutput of key products stood at 7,976,000 tonnes, up 7% year-on-year.Sales...